As of 2025-07-16, the Relative Valuation of Global Blood Therapeutics Inc (GBT) is (102.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on Relative Valuation is -249.0%.
The range of the Relative Valuation is (83.06) - (113.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 23.8x | 19.8x |
| Forward P/E multiples | 17.4x - 28.4x | 22.9x |
| Fair Price | (83.06) - (113.83) | (102.03) |
| Upside | -221.3% - -266.2% | -249.0% |
| Date | P/E |